Additional Information for Diatrizoate Meglumine Injection
Diatrizoate Meglumine Injection is a type of contrast agent used in medical imaging procedures such as X-rays, computed tomography (CT) scans, and angiography. It belongs to the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Contrast agents like Diatrizoate Meglumine Injection are used to enhance the visibility of certain tissues or blood vessels during imaging procedures. They contain substances that are opaque to X-rays or other imaging techniques, allowing the radiologist or healthcare provider to better visualize specific areas of the body.
Diatrizoate Meglumine Injection is typically administered intravenously, meaning it is injected into a vein. It helps to highlight blood vessels, organs, or other structures of interest, making them more visible on the resulting images. This can aid in the diagnosis and evaluation of various medical conditions.
It is important to note that Diatrizoate Meglumine Injection should only be used under the supervision of a healthcare professional, as it may have potential side effects or contraindications. The specific dosage and administration instructions will depend on the individual patient and the imaging procedure being performed.
If you have any further questions or need more information, please let me know.
Related Item Names for INC 23817 Diatrizoate Meglumine Injection
NATO Stock Numbers with Item Name 23817 Diatrizoate Meglumine Injection Page 1 of 1
- 02-0172
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC00270-0832-60
- RNCC: 3 | RNVC: 2 | DAC: 4
- HYPAQUE-CYSTO
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC00003-1410-35
- RNCC: 5 | RNVC: 9 | DAC: 4
- NDC00407-0734-10
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00270-0696-25
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00003-0809-76
- RNCC: 5 | RNVC: 9 | DAC: 4
- NDC00407-0739-10
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00407-0746-04
- RNCC: 3 | RNVC: 1 | DAC: 4
- CYSTOGRAFIN DILUTE
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC00407-0749-20
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00003-0696-17
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC50419-0196-30
- RNCC: 3 | RNVC: 2 | DAC: 6
- NDC50419-0192-85
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00003-0804-45
- RNCC: 3 | RNVC: 2 | DAC: 4
- ANGIOVIST 282
- RNCC: 5 | RNVC: 1 | DAC: 6
- ANGIOVIST 282
- RNCC: 5 | RNVC: 1 | DAC: 4
- RENO-M-30
- RNCC: 5 | RNVC: 9 | DAC: 6
- NDC50419-0192-15
- RNCC: 3 | RNVC: 2 | DAC: 6
- NDC00003-0696-65
- RNCC: 3 | RNVC: 2 | DAC: 4
- HYPAQUE MEGLUMINE
- RNCC: 5 | RNVC: 9 | DAC: 4
- REN0M30
- RNCC: 3 | RNVC: 9 | DAC: 4
- NDC0003-0696-55
- RNCC: 3 | RNVC: 2 | DAC: 4
- UROVIST ANGIOGRAFIN % 65 30 ML.-
- RNCC: 3 | RNVC: 2 | DAC: 6
- 842880
- RNCC: 3 | RNVC: 2 | DAC: 3
- 630004
- RNCC: 3 | RNVC: 2 | DAC: 3
- 842872
- RNCC: 3 | RNVC: 2 | DAC: 3